Two Sigma Advisers’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $813K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $6.14M | Sell |
|
|||||
|
2022
Q4 | $77M | Sell |
|
|||||
|
2022
Q3 | $133M | Buy |
|
|||||
|
2022
Q2 | $17.7M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $39.9M | Sell |
|
|||||
|
2021
Q3 | $127M | Buy |
|
|||||
|
2021
Q2 | $2.4M | Sell |
|
|||||
|
2021
Q1 | $27.4M | Buy |
|
|||||
|
2020
Q4 | $4.45M | Sell |
|
|||||
|
2020
Q3 | $68M | Sell |
|
|||||
|
2020
Q2 | $101M | Buy |
|
|||||
|
2020
Q1 | $17.4M | Buy |
|
|||||
|
2019
Q4 | $1.85M | Sell |
|
|||||
|
2019
Q3 | $19.3M | Buy |
|
|||||
|
2019
Q2 | $15.2M | Sell |
|
|||||
|
2019
Q1 | $29.1M | Buy |
|
|||||
|
2018
Q4 | $25M | Sell |
|
|||||
|
2018
Q3 | $26.4M | Sell |
|
|||||
|
2018
Q2 | $40.2M | Sell |
|
|||||
|
2018
Q1 | $88.4M | Sell |
|
|||||
|
2017
Q4 | $180M | Buy |
|
|||||
|
2017
Q3 | $132M | Buy |
|
|||||
|
2017
Q2 | $118M | Buy |
|
|||||
|
2017
Q1 | $100M | Sell |
|
|||||
|
2016
Q4 | $94.1M | Buy |
|
|||||
|
2016
Q3 | $7.06M | Buy |
|
|||||
|
2016
Q2 | $849K | Sell |
|
|||||
|
2016
Q1 | $4.21M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $12.3M | Sell |
|
|||||
|
2015
Q2 | $34.4M | Buy |
|
|||||
|
2015
Q1 | $18.8M | Sell |
|
|||||
|
2014
Q4 | $30.6M | Sell |
|
|||||
|
2014
Q3 | $61.9M | Buy |
|
|||||
|
2014
Q2 | $49.1M | Buy |
|
|||||
|
2014
Q1 | $42M | Buy |
|
|||||
|
2013
Q4 | $17.9M | Buy |
|
|||||
|
2013
Q3 | $8.92M | Buy |
|
|||||
|
2013
Q2 | $8.16M | Buy |
|